Good, S. S., Westover, J., Jung, K. H., Zhou, X., Moussa, A., La Colla, P., . . . Sommadossi, J. (2021). AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19. Antimicrob Agents Chemother.
Styl ChicagoGood, Steven S., Jonna Westover, Kie Hoon Jung, Xiao-Jian Zhou, Adel Moussa, Paolo La Colla, Gabriella Collu, Bruno Canard, a Jean-Pierre Sommadossi. "AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19." Antimicrob Agents Chemother 2021.
Citace podle MLAGood, Steven S., et al. "AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19." Antimicrob Agents Chemother 2021.